Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1436-3305
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo ; volume:18 ; number:3 ; day:24 ; month:6 ; year:2014 ; pages:627-634 ; date:7.2015
Gastric cancer ; 18, Heft 3 (24.6.2014), 627-634, 7.2015
- Urheber
-
Poole, Chris D.
- Beteiligte Personen und Organisationen
-
Connolly, Mark P.
Chang, Jane
Currie, Craig J.
SpringerLink (Online service)
- DOI
-
10.1007/s10120-014-0391-x
- URN
-
urn:nbn:de:1111-201609109457
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Poole, Chris D.
- Connolly, Mark P.
- Chang, Jane
- Currie, Craig J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
Placebo
Neural Mechanisms of Placebo Anxiolysis
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
An enactive account of placebo effects
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Neural circuit basis of placebo pain relief
Role of placebo samples in observational studies
Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
76. Placebo domino
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
Placebo
Neural Mechanisms of Placebo Anxiolysis
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
An enactive account of placebo effects
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Neural circuit basis of placebo pain relief
Role of placebo samples in observational studies
Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
76. Placebo domino
Regorafenib bei GIST : neuer Therapie-Standard bei Progress nach Imatinib und Sunitinib
Effect of gastrointestinal resection on sunitinib exposure in patients with GIST
Placebo
Neural Mechanisms of Placebo Anxiolysis
Toxicity management of regorafenib in patients with gastro-intestinal stromal tumour (GIST) in a tertiary cancer centre
An enactive account of placebo effects
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
Placebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo
Neural circuit basis of placebo pain relief
Role of placebo samples in observational studies
Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms